Gem Aromatics Limited has announced the successful completion of its postal ballot process for appointing a new director to its board. The company's shareholders have overwhelmingly approved the appointment of Mr. Shrenik Kishorbhai Vora as Non-Executive, Non-Independent Director through electronic voting.

Voting Results and Approval

The postal ballot concluded on February 07, 2026, with shareholders demonstrating strong support for the proposed appointment. The resolution received requisite majority approval as mandated under corporate governance norms.

Director Appointment Details

Mr. Shrenik Kishorbhai Vora, bearing Director Identification Number (DIN) 08688950, has been appointed as Non-Executive, Non-Independent Director of the company. The appointment follows proper corporate governance procedures and regulatory compliance requirements.

Scrutinizer and Process Compliance

The postal ballot process was conducted under the supervision of Mr. Vishwanath, a Practising Company Secretary (ACS: 14521; CP: 25099) and Designated Partner of M/s Sharma and Trivedi LLP. The scrutinizer was appointed by the Board of Directors on January 07, 2026.

Regulatory Compliance and Documentation

The postal ballot was conducted in accordance with Section 108 and Section 110 of the Companies Act, 2013, along with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company followed electronic voting procedures as per MCA Circulars and SEBI guidelines, sending notices only through electronic mode to registered email addresses.

The voting results and scrutinizer's report have been made available on the company's website at www.gemaromatics.com and will be communicated to stock exchanges including NSE (Symbol: GEMAROMA) and BSE (Code: 544491). The company has 70,142 total shareholders on record date, with the resolution being deemed passed on February 07, 2026.

Gem Aromatics held its Q3 and 9-month FY26 earnings conference call, providing comprehensive updates on financial performance, facility commissioning, and strategic growth initiatives while reaffirming its ambitious revenue targets.

Q3 FY26 Financial Performance

The company reported mixed results for the quarter, with operations impacted by external headwinds but showing signs of margin improvement:

Nine-Month FY26 Performance

For the nine-month period, the company demonstrated resilience despite challenging market conditions:

Dahej Facility Commissioning

A significant milestone was achieved with the commissioning of the Greenfield Dahej facility. Commercial production commenced for WS23 and WS03 cooling agents, along with clove and eugenol verticals, effective December 11, 2025. The facility represents a total capital expenditure of approximately ₹270 crores, with around ₹250 crores already incurred and largely capitalized.

Strategic Growth Initiatives

The company is progressing with its diversification strategy across multiple specialty chemical verticals. Phenol derivatives catalyst preparation is underway, expected to complete by Q4 FY26, with trial production of Anisole, MEHQ, and Guaiacol planned for Q1 FY27. The facility has successfully completed first-stage audits for multiple international compliance standards including FSSC 22000 Version 6, GHP, HACCP, and ISO certifications.

Reaffirmed Financial Targets

Despite current headwinds from tariff-related uncertainties and GST changes affecting customer procurement behavior, Gem Aromatics maintains its ambitious financial projections:

Management expressed confidence in achieving these targets through improved product mix, automation benefits, enhanced asset utilization, and geographic expansion, particularly with the India-EU trade deal developments providing additional growth opportunities.